Table 2 Clinicopathological findings of the 47 cases of PanNET
From: Apoptosis-related factors are relevant to progression of pancreatic neuroendocrine tumors
Characteristics | n = 47 |
|---|---|
Age (years) | 61.7 ± 13.9 |
Sex (Female/Male) | 35 (74.5%)/12 (25.5%) |
Tumor location (Ph/Pbt) | 13 (27.7%)/34 (72.3%) |
Operation (PD/DP/Others) | 13 (27.7%)/30 (63.8%)/4 (8.5%) |
Tumor size (mm) | 21.4 ± 20.1 |
Vascular invasion (negative/positive) | 41 (87.2%)/6 (12.8%) |
Extrapancreatic invasion (negative/positive) | 42 (89.4%)/5 (10.6%) |
Functionality (non-functional/functional) | 34 (72.3%)/13 (27.7%) |
UICC Stage | |
T-stage (T1/T2/T3/T4) | 33 (70.2%)/10 (21.3%)/4 (8.5%)/0 (0%) |
N-stage (N0/N1) | 42 (89.4%)/5 (10.6%) |
M-stage (M0/M1) | 45 (95.7%)/2 (4.3%) |
p-Stage (I/II/III/IV) | 31 (65.9%)/10 (21.3%)/4 (8.5%)/2 (4.3%) |
Mitoses / 2mm2 (< 2/ ≥ 2) | 39 (83.0%)/8 (17.0%) |
Ki-67 proliferation index (< 3%/ ≥ 3%) | 39 (83.0%)/8 (17.0%) |
Grade (G1/G2/G3) | 37 (78.7%)/9 (19.1%)/1 (2.1%) |
Recurrence (negative/positive) | 41 (87.2%)/6 (12.8%) |